Patient2Sentence: Semantic Compression of Clinical Trial Eligibility Using Large Language Models
Yoshinari, G. H.; Goulart, W. C. S.; Urbano, A. B. O.; Rabello, M. M.; Macedo, S. O.
Show abstract
Clinical decision-making generates vast unstructured data that remain underexploited for trial recruitment. We present Patient2Sentence (P2S), a framework that transforms electronic health records into language-based representations to enable automated eligibility screening for oncology trials. Using synthetic patient records derived from three completed breast cancer studies (KATHERINE, MONARCH, and OLYMPIA), we created 25 virtual patients per trial and compared eligibility classification between full records and their condensed "patient sentences." P2S achieved a mean concordance of 93.2% (95% CI 89.8-96.6%; Cohens {kappa} = 0.91) between sentence-level and full-record decisions while reducing token usage by ~67%. This compression preserved semantic fidelity and reduced computational cost approximately threefold. By encoding heterogeneous clinical data into compact natural-language form, P2S provides a reproducible and efficient approach to patient-trial matching, with potential applications across diverse clinical decision-support systems.
Matching journals
The top 1 journal accounts for 50% of the predicted probability mass.
Similar papers in this journal
- Histology-based Prediction of Therapy Response to Neoadjuvant Chemotherapy for Esophageal and Esophagogastric Junction Adenocarcinomas Using Deep Learning 94%
- DeepPhe-CR: Natural Language Processing Software Services for Cancer Registrar Case Abstraction 94%
- Large language models to help appeal denied radiotherapy services 93%
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- Low adherence to existing model reporting guidelines by commonly used clinical prediction models 91%
- Diagnostic Codes in AI prediction models and Label Leakage of Same-admission Clinical Outcomes 90%
- A Crowdsourcing Approach to Develop Machine Learning Models to Quantify Radiographic Joint Damage in Rheumatoid Arthritis 90%
Similar papers in this journal
- Clinical interpretation of integrative molecular profiles to guide precision cancer medicine 95%
- Decoding pan-cancer treatment outcomes using multimodal real-world data and explainable artificial intelligence 94%
- Additivity predicts the efficacy of most approved combination therapies for advanced cancer 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.